Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis
Clinical trial NCT02494479 · COMPLETED
Trial details
- NCT number
- NCT02494479
- Sponsor
- Cellceutix Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2016-04-01
- Enrollment
- 115
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.